Scott’s practice includes US, Canadian and international patent prosecution as well as licensing and other technology development agreements.
His work is focused on climate and medtech, including experience with medical devices, drug delivery, bioreactors, nanotechnology, membranes, water treatment, building science and reduced carbon technologies.
Scott is an active angel investor. He is a member of Element 8, a cleantech focused angel group, and a member of the board of the Golden Triangle Angel Network (GTAN).